Hizmetler
Our Team has experience in the following fields
Cell Therapy in Gastrointestinal Diseases
Compared to other conventional therapies, this new treatment is associated with an acceptable success rate for treating severe and chronic diseases such as fecal incontinence, fistula, rectal prolapse, intestinal trauma due to radiation, inflammatory bowel disease such as Crohn’s disease and ulcerative colitis, autoimmune biliary system diseases, liver disease and liver transplants in the field of gastrointestinal diseases.
In Iran, with the benefit of long and sufficient experience of medical teams in the field of stem cell transplantation significant success has been reported in the results of the stem cell transplantation. The success rate of this treatment in Iran has been estimated according to advanced countries. The list of patient costs for stem cell therapy at a Hospital in Tehran includes the following, depending on the type and duration of disease:
- Pre-transplantation practice: routine tests, chromosomal tests, CT scans, MRI and counseling.
- Transplantation and admission for one week depending on the type and severity of the disease.
- Stay in Tehran for periodic visits and continue treatment for two months depending on the patient s condition.
- The duration of the patient s stay in Iran is on average 5 days before the transplantation and two months after the transplantation outside the hospital. The duration of admission is approximately one day to one month. It should be noted that the hospital has no commitment to undergo pre-transplantation examinations, as well as the accommodation of patients other than hospitalization time.
Patients and companions during their stay in Iran can benefit from hotel-based hospitality services and hospitality hotels, which are naturally calculated and announced separately.
Cell Therapy in Nervous System Diseases
Compared to other conventional therapies, this new treatment is associated with an acceptable success rate for treating severe and chronic diseases such as stroke, Parkinson’s disease, multiple sclerosis, amyotrophic lateral sclerosis, Alzheimer’s disease, cerebral palsy stroke, spinal cord injuries, and neuropathies in the field of neurological diseases.
In Iran, with the benefit of long and sufficient experience of medical teams in the field of stem cell transplantation significant success has been reported in the results of the stem cell transplantation. The success rate of this treatment in Iran has been estimated according to advanced countries. The list of patient costs for stem cell therapy at a Hospital in Tehran includes the following, depending on the type and duration of disease:
- Pre-transplantation practice: routine tests, chromosomal tests, CT scans, MRI and counseling.
- Transplantation and admission for one week depending on the type and severity of the disease.
- Stay in Tehran for periodic visits and continue treatment for two months depending on the patient s condition.
- The duration of the patient s stay in Iran is on average 5 days before the transplantation and two months after the transplantation outside the hospital. The duration of admission is approximately one day to one month. It should be noted that the hospital has no commitment to undergo pre-transplantation examinations, as well as the accommodation of patients other than hospitalization time.
Patients and companions during their stay in Iran can benefit from hotel-based hospitality services and hospitality hotels, which are naturally calculated and announced separately.
Cell Therapy in Reconstructive and Plastic Surgery
Compared to other conventional therapies, this new treatment is associated with an acceptable success rate for treating severe and chronic diseases such as burn wounds, scars, reconstruction procedure, soft tissue defects, acute and chronic ulcers, facial cosmetic procedure, maxillofacial disorders, skull and limbs bone deformities, as well as cosmetic procedures such as breast, buttock and cheek augmentations and rejuvenation.
In Iran, with the benefit of long and sufficient experience of medical teams in the field of stem cell transplantation significant success has been reported in the results of the stem cell transplantation. The success rate of this treatment in Iran has been estimated according to advanced countries. The list of patient costs for stem cell therapy at a Hospital in Tehran includes the following, depending on the type and duration of disease:
- Pre-transplantation practice: routine tests, chromosomal tests, CT scans, MRI and counseling.
- Transplantation and admission for one week depending on the type and severity of the disease.
- Stay in Tehran for periodic visits and continue treatment for two months depending on the patient s condition.
- The duration of the patient s stay in Iran is on average 5 days before the transplantation and two months after the transplantation outside the hospital. The duration of admission is approximately one day to one month. It should be noted that the hospital has no commitment to undergo pre-transplantation examinations, as well as the accommodation of patients other than hospitalization time.
Patients and companions during their stay in Iran can benefit from hotel-based hospitality services and hospitality hotels, which are naturally calculated and announced separately.
Cell Therapy in Endocrine Disorders
Compared to other conventional therapies, this new treatment is associated with an acceptable success rate for treating severe and chronic diseases such as type 1 and type 2 diabetes, diabetic neuropathies, diabetic ulcers, diabetic cardiomyopathy and diabetic nephropathy in the field of endocrine diseases.
In Iran, with the benefit of long and sufficient experience of medical teams in the field of stem cell transplantation significant success has been reported in the results of the stem cell transplantation. The success rate of this treatment in Iran has been estimated according to advanced countries. The list of patient costs for stem cell therapy at a Hospital in Tehran includes the following, depending on the type and duration of disease:
- Pre-transplantation practice: routine tests, chromosomal tests, CT scans, MRI and counseling.
- Transplantation and admission for one week depending on the type and severity of the disease.
- Stay in Tehran for periodic visits and continue treatment for two months depending on the patient s condition.
- The duration of the patient s stay in Iran is on average 5 days before the transplantation and two months after the transplantation outside the hospital. The duration of admission is approximately one day to one month. It should be noted that the hospital has no commitment to undergo pre-transplantation examinations, as well as the accommodation of patients other than hospitalization time.
Patients and companions during their stay in Iran can benefit from hotel-based hospitality services and hospitality hotels, which are naturally calculated and announced separately.
Cell Therapy in Neuromuscular Disorders
Compared to other conventional therapies, this new treatment is associated with an acceptable success rate for treating severe and chronic diseases such as muscular dystrophies, polymyalgia rheumatic, spinal muscular atrophies, motor neuron disease, muscle disorders, myasthenia gravis and congenital neuromuscular disorders in the field of neuromuscular diseases.
In Iran, with the benefit of long and sufficient experience of medical teams in the field of stem cell transplantation significant success has been reported in the results of the stem cell transplantation. The success rate of this treatment in Iran has been estimated according to advanced countries. The list of patient costs for stem cell therapy at a Hospital in Tehran includes the following, depending on the type and duration of disease:
- Pre-transplantation practice: routine tests, chromosomal tests, CT scans, MRI and counseling.
- Transplantation and admission for one week depending on the type and severity of the disease.
- Stay in Tehran for periodic visits and continue treatment for two months depending on the patient s condition.
- The duration of the patient s stay in Iran is on average 5 days before the transplantation and two months after the transplantation outside the hospital. The duration of admission is approximately one day to one month. It should be noted that the hospital has no commitment to undergo pre-transplantation examinations, as well as the accommodation of patients other than hospitalization time.
Patients and companions during their stay in Iran can benefit from hotel-based hospitality services and hospitality hotels, which are naturally calculated and announced separately.
Cell Therapy in kidney Diseases
Compared to other conventional therapies, this new treatment is associated with an acceptable success rate for treating severe and chronic diseases such as autoimmune renal diseases, acute and chronic renal failure, nephropathy due to various diseases such as diabetes, acute and chronic kidney injury and kidney transplant in the field of urinary system diseases.
In Iran, with the benefit of long and sufficient experience of medical teams in the field of stem cell transplantation significant success has been reported in the results of the stem cell transplantation. The success rate of this treatment in Iran has been estimated according to advanced countries. The list of patient costs for stem cell therapy at a Hospital in Tehran includes the following, depending on the type and duration of disease:
- Pre-transplantation practice: routine tests, chromosomal tests, CT scans, MRI and counseling.
- Transplantation and admission for one week depending on the type and severity of the disease.
- Stay in Tehran for periodic visits and continue treatment for two months depending on the patient s condition.
- The duration of the patient s stay in Iran is on average 5 days before the transplantation and two months after the transplantation outside the hospital. The duration of admission is approximately one day to one month. It should be noted that the hospital has no commitment to undergo pre-transplantation examinations, as well as the accommodation of patients other than hospitalization time.
Patients and companions during their stay in Iran can benefit from hotel-based hospitality services and hospitality hotels, which are naturally calculated and announced separately.
Cell Therapy in Cardiovascular Diseases
Compared to other conventional therapies, this new treatment is associated with an acceptable success rate for treating severe and chronic diseases such as coronary artery disease, heart attack, cardiac arrhythmias, peripheral vascular disease, and various cardiomyopathies in the field of cardiovascular disease.
In Iran, with the benefit of long and sufficient experience of medical teams in the field of stem cell transplantation significant success has been reported in the results of the stem cell transplantation. The success rate of this treatment in Iran has been estimated according to advanced countries. The list of patient costs for stem cell therapy at a Hospital in Tehran includes the following, depending on the type and duration of disease:
- Pre-transplantation practice: routine tests, chromosomal tests, CT scans, MRI and counseling.
- Transplantation and admission for one week depending on the type and severity of the disease.
- Stay in Tehran for periodic visits and continue treatment for two months depending on the patient s condition.
- The duration of the patient s stay in Iran is on average 5 days before the transplantation and two months after the transplantation outside the hospital. The duration of admission is approximately one day to one month. It should be noted that the hospital has no commitment to undergo pre-transplantation examinations, as well as the accommodation of patients other than hospitalization time.
Patients and companions during their stay in Iran can benefit from hotel-based hospitality services and hospitality hotels, which are naturally calculated and announced separately.
Cell Therapy in Bone and Orthopedic Diseases
Compared to other conventional therapies, this new treatment is associated with an acceptable success rate for treating severe and chronic diseases such as osteoarthritis, fracture union defects, cartilage lesions, frozen shoulder, meniscus tearing, ligament tearing, avascular necrosis, disc herniation and chronic low back pain in the field of orthopedic diseases.
In Iran, with the benefit of long and sufficient experience of medical teams in the field of stem cell transplantation significant success has been reported in the results of the stem cell transplantation. The success rate of this treatment in Iran has been estimated according to advanced countries. The list of patient costs for stem cell therapy at a Hospital in Tehran includes the following, depending on the type and duration of disease:
- Pre-transplantation practice: routine tests, chromosomal tests, CT scans, MRI and counseling.
- Transplantation and admission for one week depending on the type and severity of the disease.
- Stay in Tehran for periodic visits and continue treatment for two months depending on the patient s condition.
- The duration of the patient s stay in Iran is on average 5 days before the transplantation and two months after the transplantation outside the hospital. The duration of admission is approximately one day to one month. It should be noted that the hospital has no commitment to undergo pre-transplantation examinations, as well as the accommodation of patients other than hospitalization time.
Patients and companions during their stay in Iran can benefit from hotel-based hospitality services and hospitality hotels, which are naturally calculated and announced separately.
Cell Therapy in Autoimmune Diseases
Compared to other conventional therapies, this new treatment is associated with an acceptable success rate for treating severe and chronic diseases such as rheumatoid arthritis, systemic lupus erythematous, Crohn’s disease, ulcerative colitis, connective tissue autoimmune diseases, Behçet disease, Sjogren’s syndrome, psoriasis, Guillain-Barre syndrome, GVHD and vasculitis in the field of autoimmune diseases.
In Iran, with the benefit of long and sufficient experience of medical teams in the field of stem cell transplantation significant success has been reported in the results of the stem cell transplantation. The success rate of this treatment in Iran has been estimated according to advanced countries. The list of patient costs for stem cell therapy at a Hospital in Tehran includes the following, depending on the type and duration of disease:
- Pre-transplantation practice: routine tests, chromosomal tests, CT scans, MRI and counseling.
- Transplantation and admission for one week depending on the type and severity of the disease.
- Stay in Tehran for periodic visits and continue treatment for two months depending on the patient s condition.
- The duration of the patient s stay in Iran is on average 5 days before the transplantation and two months after the transplantation outside the hospital. The duration of admission is approximately one day to one month. It should be noted that the hospital has no commitment to undergo pre-transplantation examinations, as well as the accommodation of patients other than hospitalization time.
Patients and companions during their stay in Iran can benefit from hotel-based hospitality services and hospitality hotels, which are naturally calculated and announced separately.
Cell Therapy in Obstetrics and Gynecology, Urology and Infertility
Compared to other conventional therapies, this new treatment is associated with an acceptable success rate for treating severe and chronic diseases such as urinary incontinence, vaginal prolapse, vaginal fistula and infertility in women and men such as ovarian failure and non-obstructive azoospermia in the field of obstetrics and gynecology, urology and infertility.
In Iran, with the benefit of long and sufficient experience of medical teams in the field of stem cell transplantation significant success has been reported in the results of the stem cell transplantation. The success rate of this treatment in Iran has been estimated according to advanced countries. The list of patient costs for stem cell therapy at a Hospital in Tehran includes the following, depending on the type and duration of disease:
- Pre-transplantation practice: routine tests, chromosomal tests, CT scans, MRI and counseling.
- Transplantation and admission for one week depending on the type and severity of the disease.
- Stay in Tehran for periodic visits and continue treatment for two months depending on the patient s condition.
- The duration of the patient s stay in Iran is on average 5 days before the transplantation and two months after the transplantation outside the hospital. The duration of admission is approximately one day to one month. It should be noted that the hospital has no commitment to undergo pre-transplantation examinations, as well as the accommodation of patients other than hospitalization time.
Patients and companions during their stay in Iran can benefit from hotel-based hospitality services and hospitality hotels, which are naturally calculated and announced separately.
Cell Therapy in Dermatology and Cosmetic
Compared to other conventional therapies, this new treatment is associated with an acceptable success rate for treating severe and chronic diseases such as scleroderma, butterfly disease, Alopecia areata, Lichen plan, skin scars, skin problems such as hyperpigmentation, stretch mark, wrinkle, hair problems, and skin rejuvenation in the field of dermatology and cosmetic.
In Iran, with the benefit of long and sufficient experience of medical teams in the field of stem cell transplantation significant success has been reported in the results of the stem cell transplantation. The success rate of this treatment in Iran has been estimated according to advanced countries. The list of patient costs for stem cell therapy at a Hospital in Tehran includes the following, depending on the type and duration of disease:
- Pre-transplantation practice: routine tests, chromosomal tests, CT scans, MRI and counseling.
- Transplantation and admission for one week depending on the type and severity of the disease.
- Stay in Tehran for periodic visits and continue treatment for two months depending on the patient s condition.
- The duration of the patient s stay in Iran is on average 5 days before the transplantation and two months after the transplantation outside the hospital. The duration of admission is approximately one day to one month. It should be noted that the hospital has no commitment to undergo pre-transplantation examinations, as well as the accommodation of patients other than hospitalization time.
Patients and companions during their stay in Iran can benefit from hotel-based hospitality services and hospitality hotels, which are naturally calculated and announced separately.
Cell Therapy in Ophthalmology
Compared to other conventional therapies, this new treatment is associated with an acceptable success rate for treating severe and chronic diseases such as congenital and acquired retinopathies, autoimmune neuropathies, retinitis pigmentosa, cornea disorders, and autoimmune diseases in the field of eye diseases.
In Iran, with the benefit of long and sufficient experience of medical teams in the field of stem cell transplantation significant success has been reported in the results of the stem cell transplantation. The success rate of this treatment in Iran has been estimated according to advanced countries. The list of patient costs for stem cell therapy at a Hospital in Tehran includes the following, depending on the type and duration of disease:
- Pre-transplantation practice: routine tests, chromosomal tests, CT scans, MRI and counseling.
- Transplantation and admission for one week depending on the type and severity of the disease.
- Stay in Tehran for periodic visits and continue treatment for two months depending on the patient s condition.
- The duration of the patient s stay in Iran is on average 5 days before the transplantation and two months after the transplantation outside the hospital. The duration of admission is approximately one day to one month. It should be noted that the hospital has no commitment to undergo pre-transplantation examinations, as well as the accommodation of patients other than hospitalization time.
Patients and companions during their stay in Iran can benefit from hotel-based hospitality services and hospitality hotels, which are naturally calculated and announced separately.
Cell Therapy in Pulmonary Diseases
Compared to other conventional therapies, this new treatment is associated with an acceptable success rate for treating severe and chronic diseases such as ARDS especially due to COVID-19, COPD, pulmonary fibrosis, autoimmune disorders, resistant asthma, sarcoidosis and pulmonary autoimmune disease in the field of lung diseases.
In Iran, with the benefit of long and sufficient experience of medical teams in the field of stem cell transplantation significant success has been reported in the results of the stem cell transplantation. The success rate of this treatment in Iran has been estimated according to advanced countries. The list of patient costs for stem cell therapy at a Hospital in Tehran includes the following, depending on the type and duration of disease:
- Pre-transplantation practice: routine tests, chromosomal tests, CT scans, MRI and counseling.
- Transplantation and admission for one week depending on the type and severity of the disease.
- Stay in Tehran for periodic visits and continue treatment for two months depending on the patient s condition.
- The duration of the patient s stay in Iran is on average 5 days before the transplantation and two months after the transplantation outside the hospital. The duration of admission is approximately one day to one month. It should be noted that the hospital has no commitment to undergo pre-transplantation examinations, as well as the accommodation of patients other than hospitalization time.
Patients and companions during their stay in Iran can benefit from hotel-based hospitality services and hospitality hotels, which are naturally calculated and announced separately.